Physician profile
Besty Jacob
NPI 1336572643
$11,312.99
in general payments reported to CMS, 2019-2025
17 companies · $1,879 in 2025
The $1,879 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,741 · 2020: $1,757 · 2021: $1,430 · 2022: $1,839 · 2023: $1,372 · 2024: $1,294 · 2025: $1,879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,420 · Travel and Lodging: $1,082 · Entertainment: $43.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,419.88 |
| Travel and Lodging | $1,081.96 |
| Entertainment | $43.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,941.09 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Optovue, INC. | $2,123.33 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $2,060.66 | 2022-2025 | Infuse |
| Johnson & Johnson Vision Care, INC. | $1,704.23 | 2019-2024 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $621.11 | 2019-2021 | |
| Alcon Vision LLC | $613.94 | 2019-2025 | Precision 1, Precision7, Dailies Total1 |
| Optos, INC. | $385.05 | 2020-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Kala Pharmaceuticals, INC. | $125.00 | 2021 | |
| Aerie Pharmaceuticals, INC. | $124.99 | 2021 | |
| New World Medical,INC. | $119.29 | 2023 | |
| Genentech USA, INC. | $108.02 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $96.07 | 2022 | |
| Glaukos Corporation | $93.12 | 2022 | |
| Visionix USA, INC | $74.99 | 2022 | |
| Harrow Eye, LLC | $68.90 | 2025 | Vevye |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $35.96 | 2024 | Tyrvaya |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Besty Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.